The inaugural Cell & Gene Therapies pipeline features three back-to-back conferences exploring the challenges, advances, and opportunities in gene and cell therapies. The conferences on Vector Design and Development for Gene and Cell Therapies, Gene
Therapy Analytics and Manufacturing, and Cell Therapy Analytics and Manufacturing will discuss critical and hot topics like engineering and development of safer and more efficacious vectors, CMC and characterization, manufacturing, scale-up, next-generation
production technologies, automation, supply chain, commercialization, and many more practical issues for the success of cell and gene therapies.
Vector Design and Development for Gene and Cell Therapies
Gene Therapy Analytics and Manufacturing
Cell Therapy Analytics and Manufacturing
Guangping Gao, PhD, Co-Director, Li Weibo Institute for Rare Diseases Research; Director, Horae Gene Therapy Center and Viral Vector Core; Professor, Microbiology and Physiological Systems, University of Massachusetts Medical School
Muthiah (Mano) Manoharan, PhD, Senior Vice President, Drug Discovery, Alnylam Pharmaceuticals, Inc.
Mo Heidaran, PhD, Vice President, Technical, PAREXEL Consulting, PAREXEL International